Cardinal Health, Inc. (NYSE:CAH) Receives $139.36 Consensus Price Target from Analysts

Cardinal Health, Inc. (NYSE:CAH) has been given a consensus rating of “Moderate Buy” by the fourteen analysts that are presently covering the company, MarketBeat Ratings reports. Four analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $139.36.

CAH has been the topic of a number of research analyst reports. Argus set a $148.00 target price on Cardinal Health in a report on Tuesday, February 4th. Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a research report on Tuesday, January 7th. Bank of America raised Cardinal Health from a “neutral” rating to a “buy” rating and raised their price objective for the company from $132.00 to $145.00 in a research report on Monday, January 6th. Mizuho assumed coverage on Cardinal Health in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price objective on the stock. Finally, Morgan Stanley raised their price objective on Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a research report on Friday, January 31st.

Institutional Trading of Cardinal Health

Several hedge funds and other institutional investors have recently bought and sold shares of CAH. Norges Bank bought a new stake in Cardinal Health in the fourth quarter valued at about $246,748,000. Marshall Wace LLP boosted its stake in Cardinal Health by 154.6% in the fourth quarter. Marshall Wace LLP now owns 3,151,736 shares of the company’s stock valued at $372,756,000 after acquiring an additional 1,913,892 shares during the period. Castlekeep Investment Advisors LLC acquired a new position in Cardinal Health in the fourth quarter valued at approximately $141,963,000. Junto Capital Management LP acquired a new position in Cardinal Health in the fourth quarter valued at approximately $92,811,000. Finally, Woodline Partners LP acquired a new position in Cardinal Health in the fourth quarter valued at approximately $87,144,000. 87.17% of the stock is owned by institutional investors.

Cardinal Health Trading Up 1.5 %

Shares of Cardinal Health stock opened at $128.20 on Thursday. Cardinal Health has a twelve month low of $93.17 and a twelve month high of $132.84. The stock has a market capitalization of $30.97 billion, a P/E ratio of 23.92, a PEG ratio of 1.49 and a beta of 0.66. The business’s fifty day moving average price is $126.33 and its 200 day moving average price is $119.38.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, sell-side analysts predict that Cardinal Health will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.58%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is currently 37.69%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.